维普中文期刊产品整合服务
52篇 您的检索式:作者名="Croston"
    题名 作者 年代 出处 被引量
1Catalytic oxidation of p-toluidine at multiwalled ftmctionalized carbon nanotubes 显示文摘Croston M Langston J Sangoi R Santhanam K S V 2002International Journal of Nanoscience2002,1,34:1
2Forecasting and stock control for intermittent demands显示文摘Croston J D 1972Operational Research Quarterly1972,23,3:1
3The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 ( TLR3 ) agonist and tumour-derived exosomes in advanced ovarian cancer 显示文摘Adams M Navabi H Croston D 2005Vaccine2005,23,1718:1
4Identification, characterization, and tissue distribution of human peroxisome proliferatoractivated receptor (PPAR) isoforms PPARgamma2 versus PPAR gammal and activation with retinoid X receptor agonists and antagonists显示文摘Mukherjee R Jow L Croston G E 1997J Biol Chem1997,272,12:1
5Identification,characterization,and tissue distribution of human peroxisome proliferator-activated receptor(PPAR) isoforms PPARgamma2 versus PPARgammal and activation with retinoid X receptor agonists and antagonists显示文摘Mukherjee R Jow L Croston G E 1997J Biol Chem1997,272,12:1
6Forecasting and stock control for intermittent demands显示文摘Croston J D 1972Operational Research Quarterly1972,42,3:1
7Identification, characterization, and tissue distribution of human peroxisome proliferators activated receptor isoforms PPARg2 versus PPARg1 and activation with retinol Ⅹ receptor agonists and antagonists显示文摘Mukherjee R Jow L Croston GE 1997J Biol Chem1997,272,:1
8Forecasting and Stock Control for Intermittent Demands显示文摘Croston J D 1972Operational Research1972,,23:1
9Identification,characterization,and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists显示文摘Mukherjee R Jow L Croston GE 1997J Biol Chem1997,272,12:1
10Forecasting and stock control for intermittent demands显示文摘Croston J D 1972Operational Research Quarterly1972,23,3:1
11The rationale for combined chemo/immunotherapy using a Toll-like receptor 3(TLR3) agonist and tumour-derived exos omes in advanced ovarian cancer显示文摘Adams M Navabi H Croston D 0,,17:1
12Preparation of human ovarian cancer ascites-derived exosomes for a clinical trail显示文摘Navabi H Croston D Hobot J 2005Blood Cells Mol Dis2005,35,2:1
13Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial显示文摘 Croston D Hobot J 2005Blood Cells Mol Dis2005,35,2:1
14Forecasting and stock control for intermittent demands 显示文摘Croston J D 1972Operational Research Quarterly1972,23,3:1
15Forecasting and stock control for intermittent demands显示文摘Croston J D 1972Operational Research Quarterly1972,23,3:1
16Forecasting and stock control for intermittent demands显示文摘J D Croston 1972Oper Res Quart1972,23,3:1
17Catalytic oxidation of p-toluidine atmultiwalled funationalized carbon nanotubes显示文摘Croston M Langston J Sangoly R 2002International Journal of Nanoscience2002,1,34:1
18Forecasting and stock control for intermittent demands显示文摘Croston J D 1972Operational Research Quarterly1972,23,3:1
19On the categorization of demand patterns 显示文摘SYNTETOS A A BOYLAN J E CROSTON J D 2005Journal of the Operational Research Society2005,56,5:1
20Forecasting and stock control for intermittent demands 显示文摘CROSTON J D 1972Operational Research Quarterly1972,23,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费